Up­dat­ed: Mod­er­na part­ners with Black­stone on flu shots, nab­bing up to $750M in R&D fund­ing

Mod­er­na an­nounced Wednes­day that it is team­ing up with Black­stone for its in­fluen­za pro­gram.

Un­der the col­lab­o­ra­tion, Black­stone will pro­vide “up to $750 mil­lion,” ac­cord­ing to press re­leas­es, with Black­stone el­i­gi­ble for undis­closed com­mer­cial mile­stones and low sin­gle-dig­it roy­al­ties. It wasn’t im­me­di­ate­ly clear Wednes­day morn­ing how much of the fund­ing would be avail­able to Mod­er­na right away. Shares of the biotech $MR­NA are up 3% pre­mar­ket.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER